Table 2.

Disease activity scores and inflammatory mediators throughout the study in DAS28 responders and nonresponders.

	DAS28 Responders				DAS28 Nonresponders
	Baseline	2 months	4 months	p	Baseline	2 months	4 months	p
No. tender joints	19 ± 7*	7 ± 6	4 ± 4	< 0.0001	12 ± 8*	9 ± 8	11 ± 9	0.135
No. swollen joints	9 ± 4	4 ± 3	2 ± 2	< 0.0001	9 ± 5	6 ± 4	6 ± 3	0.021
DAS28-CRP	6.46 ± 0.68*	4.03 ± 1.15	3.46 ± 0.82	< 0.0001	5.39 ± 1.51*	4.71 ± 1.41	4.99 ± 1.38	0.023
Log₁₀CRP, mg/l	1.30 ± 0.41	0.87 ± 0.38	0.8 ± 0.35	< 0.0001	1.21 ± 0.50	1.09 ± 0.51	1.13 ± 0.55	0.493
PV, mPa.s	1.82 ± 0.18	1.67 ± 0.97	1.74 ± 0.15	0.008	1.81 ± 0.19	1.79 ± 0.22	1.77 ± 0.22	0.438
HAQ	1.87 ± 0.52*	1.67 ± 0.52	1.44 ± 0.76	0.001	1.42 ± 0.84*	1.51 ± 0.70	1.44 ± 0.69	0.224

Values are mean ± SD.
↵* p < 0.05 between DAS28 responders and nonresponders at baseline. DAS28: Disease Activity Score of 28 joints; CRP: C-reactive protein; PV; plasma viscosity; HAQ: Stanford Health Assessment Questionnaire.